The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells - Université d'Angers Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2012

The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells

Julien Balzeau
  • Fonction : Auteur
Alan Peterson
  • Fonction : Auteur
Joël Eyer
  • Fonction : Auteur
  • PersonId : 860664

Résumé

Cell-penetrating peptides (CPPs) can translocate through the plasma membrane and localize in different cell compartments providing a promising delivery system for peptides, proteins, nucleic acids, and other products. Here we describe features of a novel cell-penetrating peptide derived from the intermediate filament protein vimentin, called Vim-TBS.58-81. We show that it enters cells from a glioblastoma line via endocytosis where it distributes throughout the cytoplasm and nucleus. Moreover, when coupled to the pro-apoptogenic peptide P10, it localizes to the nucleus inhibiting cell proliferation. Thus, the Vim-TBS.58-81 peptide represents an effective vector for delivery of peptides and potentially a broad range of cargos to the nucleus.

Fichier non déposé

Dates et versions

hal-03403309 , version 1 (26-10-2021)

Identifiants

Citer

Julien Balzeau, Alan Peterson, Joël Eyer. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells. International Journal of Pharmaceutics, 2012, 423 (1), pp.77 - 83. ⟨10.1016/j.ijpharm.2011.04.067⟩. ⟨hal-03403309⟩

Collections

UNIV-ANGERS
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More